1. Home
  2. ACFN vs TELA Comparison

ACFN vs TELA Comparison

Compare ACFN & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACFN

Acorn Energy Inc.

N/A

Current Price

$19.65

Market Cap

43.8M

ML Signal

N/A

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

N/A

Current Price

$0.92

Market Cap

36.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACFN
TELA
Founded
1986
2012
Country
United States
United States
Employees
26
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
36.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ACFN
TELA
Price
$19.65
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.31
AVG Volume (30 Days)
18.5K
63.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.80
EPS
N/A
N/A
Revenue
N/A
$69,300,000.00
Revenue This Year
N/A
$18.41
Revenue Next Year
N/A
$15.20
P/E Ratio
$6.63
N/A
Revenue Growth
N/A
18.56
52 Week Low
$12.42
$0.67
52 Week High
$33.00
$2.48

Technical Indicators

Market Signals
Indicator
ACFN
TELA
Relative Strength Index (RSI) 51.95 52.67
Support Level $16.12 $0.67
Resistance Level $20.85 $0.93
Average True Range (ATR) 1.44 0.09
MACD 0.04 0.02
Stochastic Oscillator 38.66 81.37

Price Performance

Historical Comparison
ACFN
TELA

About ACFN Acorn Energy Inc.

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: